Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
…
continue reading
Nsclc Podcasts
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
1
ClinicalXchange Oncology podcasts
Clinical Care Solutions, CCS ClinicalXchange Oncology Podcast
3
4
Welcome to the Clinical Care Solutions Oncology podcast channel. Our podcast shows give you quick access to important content when you need it - at home, at your desk, or on the go.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
…
continue reading
Listen to podcasts with key opinion leaders in multiple therapy areas, discussing hot topics including topic overviews, expert opinions and conference overviews. Brought to you by the Adis Journals Group, part of Springer Nature. The primary audience for these podcasts are healthcare professionals, and are published and citable through the journals.
…
continue reading
i3 Health’s mission is to enhance the proficiency of the interprofessional healthcare team by providing evidence-based, fair-balanced CME/NCPD/CPE-approved activities that address identified professional practice gaps and unmet educational needs.
…
continue reading
Explore pivotal recommendations from the latest evidence-based clinical practice guidance with ASCO Guidelines. Join us to discover essential insights and navigate the ever-evolving landscape of cancer research and treatment.
…
continue reading
LungCancerRx is a new podcast that features conversations among oncologists and patients. From tackling logistical obstacles to handling existential questions, these discussions aim to provide empowerment, knowledge, and hope across the lung cancer community. Eric K. Singhi, MD, a thoracic oncologist in Houston; Aakash Desai, MD, MPH, an assistant professor at the University of Alabama Birmingham’s O’Neal Cancer Center; and Fawzi Abu Rous, MD, a thoracic medical oncologist at Henry Ford Heal ...
…
continue reading
In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers, hematologic malignancies, gynecologic cancers, genitourinary cancers, and more.
…
continue reading
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healt ...
…
continue reading
Physicians' Education Resource® (PER®) is committed to advancing patient care through professional education. This podcast is a natural extension of PER®'s efforts to provide medical education for health care providers to stay up to date with advances in medical care, from diagnosis through treatment, with the ultimate goal of improving patient outcomes. Visit www.gotoper.com for more information.
…
continue reading
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.
…
continue reading
Oncology On The Go is a weekly podcast that talks to authors and experts to thoroughly examine featured articles in the journal ONCOLOGY and review other challenging treatment scenarios in the cancer field from a multidisciplinary perspective. Our discussions also offer timely insight into topics ranging from recent FDA approvals to relevant research presented at major oncology conferences. As the home of the journal ONCOLOGY, CancerNetwork offers different perspectives on oncology/hematolog ...
…
continue reading
Welcome to The Onco Life Podcast, your trusted source for cancer care insights, treatment updates, and patient-centered education. Hosted by the team at Onco Life Centre in Kuala Lumpur, Malaysia, this podcast is designed to guide patients, caregivers, and listeners through every stage of the cancer journey. Each episode features expert advice from our oncologists, wellness tips, treatment innovations, and answers to the most common questions about cancer types, therapies, and recovery. 🎧 Em ...
…
continue reading
The Journal of Clinical Oncology podcast, hosted by Dr. Shannon Westin and Dr. Davide Soldato, presents analyses and discussions centered on the latest findings published in ASCO’s esteemed Journal of Clinical Oncology. Through scholarly discourse and examination, this podcast is your resource for navigating oncological advancements and how they impact clinical practice. The JCO Podcast also features in depth summaries and interviews hosted by the year’s fellows in the series, JCO Article In ...
…
continue reading
1
PeerView Heart, Lung & Blood CME/CNE/CPE Audio Podcast
PVI, PeerView Institute for Medical Education
28249
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support ...
…
continue reading
1
PeerView Heart, Lung & Blood CME/CNE/CPE Video Podcast
PVI, PeerView Institute for Medical Education
25250
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support ...
…
continue reading
TSRA Podcast is an educational tool for training cardiothoracic surgeons.
…
continue reading
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
…
continue reading
MedEdTalks Pulmonology is a continuing medical education podcast for physicians to allow them to learn while on the go and obtain CME credits. The intended audience for this show is pulmonologists, internists, rheumatologists and other health care professionals.
…
continue reading
1
PeerView Immunology & Transplantation CME/CNE/CPE Video Podcast
PVI, PeerView Institute for Medical Education
34100
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support ...
…
continue reading
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, cardiology, women's health and more. And our CME library is continuously growing, every quarter.
…
continue reading
1
PeerView Immunology & Transplantation CME/CNE/CPE Audio Podcast
PVI, PeerView Institute for Medical Education
66101
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support ...
…
continue reading
MedEdTalks Oncology is a continuing medical education podcast for physicians to allow them to learn while on the go and obtain CME credits. This show will focus in on different oncology topics, starting with PTCL. In the first season, we will be talking with Dr. Owen O'Connor from Columbia University in New York City, Dr. Tim Illidge from University of Manchester in the United Kingdom and Dr. Lorenz Trumper from Göttingen University in Germany.
…
continue reading
Catch up on the latest updates on non-small cell lung cancer treatment from the 2024 American Society of Clinical Oncology Annual Meeting, the World Conference on Lung Cancer, and the European Society for Medical Oncology Congress in this exclusive conference coverage series.
…
continue reading
With one in two of us receiving a cancer diagnosis at some point during our lives, it has never been more important to improve the outcomes for people affected by cancer. This cancer research podcast is brought to you by The University of Manchester in partnership with the Manchester Cancer Research Centre (MCRC). In each episode, our cancer researchers discuss the innovations, discoveries and projects that are changing the landscape of early detection.
…
continue reading
1
FDA Approves Zongertinib (Hernexeos): First Oral HER2-Targeted Therapy for Advanced NSCLC
17:02
17:02
Play later
Play later
Lists
Like
Liked
17:02
In this episode, we break down the FDA’s historic approval of zongertinib (Hernexeos), the first oral HER2-targeted therapy for advanced non-small cell lung cancer (NSCLC) with HER2 mutations. This milestone offers patients and clinicians a long-awaited, convenient, and effective treatment option. You’ll learn: Why have HER2-mutated NSCLC patients …
…
continue reading
1
S13 Ep49: Distinguishing Pathway to Precision for c-Met and MET Alterations in NSCLC
24:55
24:55
Play later
Play later
Lists
Like
Liked
24:55
In this podcast, experts Erminia Massarelli, MD, PhD, MS; Jorge J. Nieva, MD; Sandip Patel, MD; and Ignacio I. Wistuba, MD, discuss new therapies for patients with c-Met–overexpressing non–small cell lung cancer.By OncLive® On Air
…
continue reading
1
“What I Tell My Patients”: Making Sense of New Treatment Options in EGFR-positive NSCLC
31:13
31:13
Play later
Play later
Lists
Like
Liked
31:13
In this episode of LungCancerRx, Eric Singhi, MD, Aakash Desai, MD, MPH, and Fawzi F. Abu Rous, MD, welcome back Christine M. Lovly, MD, PhD, to talk about the complexities of treating advanced EGFR-positive NSCLC. Dr. Lovely shares how she talks with patients about the latest data and recent trials.…
…
continue reading
1
Additional Advances in HER2-Mutated NSCLC With Julia Kathleen Rotow, MD + Activity Module 2
24:28
24:28
Play later
Play later
Lists
Like
Liked
24:28
i3 Health recently launched an exciting new online educational activity, “What’s New with HER2: Charting New Paths in NSCLC Care.” This two-part series dives deep into the evolving role of HER2 in non–small cell lung cancer (NSCLC).In a special interview, Dr. Julia Kathleen Rotow—Clinical Director of the Lowe Center for Thoracic Oncology at Dana-Fa…
…
continue reading
1
S1 Ep173: Integrating Dato-DXd Into Early-Line EGFR-Mutant NSCLC Management
23:31
23:31
Play later
Play later
Lists
Like
Liked
23:31
In a discussion with CancerNetwork®, Jacob Sands, MD, assistant professor of Medicine at Harvard Medical School, thoracic oncologist at the Dana-Farber Cancer Institute, and investigator of the phase 2 TROPION-Lung05 trial (NCT04484142) and phase 3 TROPION-Lung01 trial (NCT04656652), which supported the accelerated approval of datopotamab deruxteca…
…
continue reading
1
S2 Ep42: Medical Crossfire®: Expert Perspectives on c-MET and MET Targeting in NSCLC—Unveiling the Complexities of MET Dysregulation
48:08
48:08
Play later
Play later
Lists
Like
Liked
48:08
Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Alex A. Adjei, MD, PhD, FACP; Sandip Patel, MD, FASCO; and Jeremy Segal, MD, PhD, discuss the emerging data and clinical strategies for targeting c-MET overexpression and MET genomic alterations in …
…
continue reading
1
S1 Ep176: START Center Aims to Bring New Cancer Treatments, Trials to The Community
0:20
0:20
Play later
Play later
Lists
Like
Liked
0:20
In a conversation with CancerNetwork®, Geraldine O’Sullivan Coyne, MD, MRCPI, PhD, spoke about her new appointment as the principal investigator and director of Clinical Research at the Northwell Health unit of the Southern Texas Accelerated Research Therapeutics (START) Center for Cancer Research. Based on a strategic partnership formed between No…
…
continue reading
1
JCO Article Insights: Lymph Node Dissection for Lung Cancer
21:49
21:49
Play later
Play later
Lists
Like
Liked
21:49
In this JCO Article Insights episode, Dr. Joseph Matthew interviews authors Dr. Yang Zhang and Dr. Haiquan Chen about their recently published JCO article, "Phase III Study of Mediastinal Lymph Node Dissection for Ground Glass Opacity–Dominant Lung Adenocarcinoma" TRANSCRIPT Joseph Mathew: Welcome to the Journal of Clinical Oncology Article Insight…
…
continue reading
1
Cardiac - Launching a Career in Robotic Cardiac Surgery: What Every Trainee Should Know (Andrea Amabile & Johannes Bonatti)
33:32
33:32
Play later
Play later
Lists
Like
Liked
33:32
Cardiac - Launching a Career in Robotic Cardiac Surgery: What Every Trainee Should Know (Andrea Amabile & Johannes Bonatti) by TSRABy TSRA
…
continue reading
1
Bone-Targeted Therapy in Prostate Cancer: How to Protect Bone Health and Reduce Fracture Risk
12:52
12:52
Play later
Play later
Lists
Like
Liked
12:52
In this episode, we explore how bone-targeted therapy supports men with advanced prostate cancer by protecting and strengthening bone health when cancer spreads to the skeleton. You’ll learn: What bone-targeted therapy is and how it works in prostate cancer care Why is bone health at risk during androgen deprivation therapy (ADT) and bone metastasi…
…
continue reading
1
Small Cell Lung Cancer — Expert Perspectives on Actual Patient Cases
58:18
58:18
Play later
Play later
Lists
Like
Liked
58:18
Dr Stephen V Liu from Georgetown University Hospital in Washington, DC and Dr Charles Rudin from Memorial Sloan Kettering Cancer Center in New York discuss the role of approved and novel investigational therapies for patients with limited-stage and extensive-stage small cell lung cancer. CME information and select publications here.…
…
continue reading
1
Radiation Therapy for Prostate Cancer: A Proven Non-Surgical Treatment for Long-Term Control
12:41
12:41
Play later
Play later
Lists
Like
Liked
12:41
In this episode, we explore how radiation therapy helps men with prostate cancer at both early and advanced stages. This non-surgical treatment delivers powerful results, especially for high-risk patients when combined with hormone therapy. You’ll learn: How modern radiation techniques like IMRT and SBRT target prostate tumors with precision Why ra…
…
continue reading
1
S13 Ep48: Refining First-Line Immunotherapy Strategies in Hepatocellular Carcinoma: With Masatoshi Kudo, MD, PhD
7:21
7:21
Play later
Play later
Lists
Like
Liked
7:21
In today’s episode, we spoke with Masatoshi Kudo, MD, about the evolving treatment landscape in hepatocellular carcinoma (HCC) and how recent comparative analyses are helping refine the use of first-line immunotherapy-based regimens. Dr Kudo is a professor and chairman in the Department of Gastroenterology and Hepatology at Kindai University Facult…
…
continue reading
1
Immunotherapy for Prostate Cancer: How Your Immune System Can Fight Back
15:03
15:03
Play later
Play later
Lists
Like
Liked
15:03
In this episode, we explore how immunotherapy is changing prostate cancer treatment by helping the body’s immune system find and attack cancer cells. This breakthrough approach gives hope to men with advanced or treatment-resistant prostate cancer. You’ll learn: What immunotherapy is and how it works to boost the immune system The role of immune ch…
…
continue reading
1
Targeted Therapy for Prostate Cancer: Precision Treatment That Protects Healthy Cells
15:33
15:33
Play later
Play later
Lists
Like
Liked
15:33
In this episode, we break down how targeted therapy is changing prostate cancer treatment by focusing directly on tumor cells while protecting healthy tissue. This new approach offers hope for men with advanced prostate cancer and gene changes such as BRCA1 and BRCA2. You’ll learn: What targeted therapy is and how it works against prostate cancer c…
…
continue reading
1
A case-based discussion on PAH: Optimizing early detection, risk stratification and treatment decision-making
37:53
37:53
Play later
Play later
Lists
Like
Liked
37:53
touchCASES for touchRESPIRATORY and touchCARDIO This touchCASES activity presents expert-led discussions exploring three clinical cases of pulmonary arterial hypertension (PAH). Through these detailed cases, the expert faculty examine a range of clinical presentations and highlight critical decision points across the patient journey, from initial d…
…
continue reading
1
Continuous glucose monitoring for cardiovascular risk reduction: The next frontier in preventive care
28:07
28:07
Play later
Play later
Lists
Like
Liked
28:07
touchEXPERT FOCUS for touchCARDIO and touchENDOCRINOLOGY Listen to two experts discuss how continuous glucose monitoring (CGM) can help identify and manage cardiovascular risk in people with or without diabetes. They explore the role of glycaemic variability, the limitations of conventional glucose metrics, and the added value of CGM, including rec…
…
continue reading
1
Treatment Optimization and Management of AEs with EV + P for Untreated Locally Advanced/Metastatic Urothelial Cancer
40:32
40:32
Play later
Play later
Lists
Like
Liked
40:32
In this podcast "Treatment Optimization and Management of AEs with Enfortumab Vedotin + Pembrolizumab for Untreated Locally Advanced/Metastatic Urothelial Cancer: A Podcast", authors discuss the management of adverse events (AEs) with enfortumab vedotin + pembrolizumab based on their personal experiences with clinical trials and in their practices …
…
continue reading
1
S13 Ep47: Multidisciplinary Collaboration Gives Forward Momentum to HER2 IHC Testing in NSCLC: With Ronan J. Kelly, MD, MBA, FASCO; and Michelle Shiller, DO, AP/CP, MGP
21:31
21:31
Play later
Play later
Lists
Like
Liked
21:31
In today’s episode, supported by Daiichi-Sankyo, we spoke with Ronan J. Kelly, MD, MBA, FASCO; and Michelle Shiller, DO, AP/CP, MGP, about HER2 immunohistochemistry (IHC) testing in non–small cell lung cancer (NSCLC). Kelly is director of the Charles A. Sammons Cancer Center and chief science officer at Baylor University Medical Center in Dallas, T…
…
continue reading
1
Chemotherapy for Prostate Cancer: How It Works, Benefits, and Side Effects Explained
11:17
11:17
Play later
Play later
Lists
Like
Liked
11:17
In this episode, we dive into chemotherapy as an important treatment option for advanced prostate cancer. While it may not cure the disease, chemotherapy helps slow cancer growth, ease symptoms, and improve quality of life for men whose cancer has spread or returned after other treatments. You’ll learn: What chemotherapy is and how it targets prost…
…
continue reading
1
Hormonal Therapy for Prostate Cancer in Malaysia: Treatment, Benefits, and What to Expect
12:56
12:56
Play later
Play later
Lists
Like
Liked
12:56
In this episode, we explore hormonal therapy as a key treatment option for prostate cancer in Malaysia. While not a cure, hormonal therapy plays a vital role in slowing cancer growth, reducing symptoms, and improving quality of life for men facing advanced prostate cancer. You’ll learn: What hormonal therapy (androgen deprivation therapy) is and ho…
…
continue reading
1
HER2 as a targetable biomarker in gastrointestinal oncology
35:30
35:30
Play later
Play later
Lists
Like
Liked
35:30
touchEXPERT FOCUS for touchONCOLOGY Listen to a series of short interviews with three leading experts as they discuss the use of HER2 as a targetable biomarker in gastrointestinal oncology. The faculty cover the clinical significance of HER2 alterations, best practices for biomarker testing, key clinical trial data on efficacy and safety, and the r…
…
continue reading
1
S13 Ep46: FDA Approval Insights: Linvoseltamab in Relapsed/Refractory Multiple Myeloma: With Nisha Joseph, MD; and Hans Lee, MD
12:38
12:38
Play later
Play later
Lists
Like
Liked
12:38
In today’s episode, we spoke with Nisha Joseph, MD, and Hans Lee, MD, about the FDA's accelerated approval of linvoseltamab-gcpt (Lynozyfic) for the treatment of adult patients with relapsed or refractory multiple myeloma who have received 4 or more prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD3…
…
continue reading
1
Understanding Stage 4 Pancreatic Cancer: Treatments, Symptoms, and Support for Families
9:49
9:49
Play later
Play later
Lists
Like
Liked
9:49
In this episode, we explore what it means to face stage 4 pancreatic cancer, covering everything from treatment options to emotional support for patients and their families. You’ll learn: What stage 4 pancreatic cancer is and how it spreads Common symptoms like fatigue, jaundice, and weight loss How chemotherapy and radiation can slow the disease a…
…
continue reading
1
Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 1 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
17:44
17:44
Play later
Play later
Lists
Like
Liked
17:44
Dr Jacob Sands from Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of non-small cell lung cancer. CME information and select publications here.
…
continue reading
1
Surgery for Prostate Cancer: Treatment Options, Benefits, and Recovery Explained
15:24
15:24
Play later
Play later
Lists
Like
Liked
15:24
In this episode, we explore surgery as a trusted and effective treatment for prostate cancer—covering the different types of procedures, their benefits, and what patients can expect during recovery. Whether you’re considering surgery yourself or supporting a loved one, this guide will help you understand the process and make informed decisions. You…
…
continue reading
1
S1 Ep175: Beyond the Tumor: Addressing Body Image in Oncology
37:35
37:35
Play later
Play later
Lists
Like
Liked
37:35
In the inaugural podcast episode created in collaboration with the American Psychosocial Oncology Society (APOS), Daniel C. McFarland, DO, and Michelle Fingeret, PhD, explored the critical, yet often overlooked, issue of body image in patients with cancer. McFarland opened the discussion by acknowledging the significant psychosocial challenges clin…
…
continue reading
1
Navigating Stage 3 Pancreatic Cancer: Treatment Options, Support Tips & What to Expect
10:35
10:35
Play later
Play later
Lists
Like
Liked
10:35
In this episode, we dive deep into what it means to face stage 3 pancreatic cancer—a locally advanced form of the disease that hasn’t spread to distant organs but may involve nearby lymph nodes and major blood vessels. You’ll learn: What defines stage 3 pancreatic cancer, and how it’s diagnosed Why aggressive treatment can still offer hope for surg…
…
continue reading
1
Understanding Stage 2 Pancreatic Cancer: Diagnosis, Treatment, and Hope for Recovery
16:21
16:21
Play later
Play later
Lists
Like
Liked
16:21
In this episode, we break down everything you need to know about stage 2 pancreatic cancer, what it means, how it's diagnosed, and the latest treatment options that offer hope for recovery. You’ll learn: The difference between stage 2A and 2B pancreatic cancer How doctors diagnose cancer using imaging, blood work, and biopsy What “borderline resect…
…
continue reading
1
Emerging DLL3-Targeted Therapies for Extrapulmonary Neuroendocrine Carcinomas
29:59
29:59
Play later
Play later
Lists
Like
Liked
29:59
In this episode, Dr. Daniel Morgensztern and Dr. Jonathan Strosberg discuss the emerging role of DLL3-targeted agents in the management of extrapulmonary neuroendocrine carcinomas, including: The clinical implications of using DLL3 as a therapeutic target The impact of emerging DLL3-targeted therapies on evolving treatment paradigms How to incorpor…
…
continue reading
1
Understanding Stage 1 Pancreatic Cancer: Early Detection, Treatment, and Survival Outlook
13:09
13:09
Play later
Play later
Lists
Like
Liked
13:09
In this episode, we explore everything you need to know about stage 1 pancreatic cancer, how it’s diagnosed, why early treatment is crucial, and what options offer the best chance for recovery. You’ll learn: What defines stage 1 pancreatic cancer, and why it more treatable The differences between stage 1A and 1B tumors How imaging and blood tests h…
…
continue reading
1
Breakthroughs in Immunotherapy for Pancreatic Cancer: How Personalized Treatment Boosts Survival
12:50
12:50
Play later
Play later
Lists
Like
Liked
12:50
In this episode, we explore how immunotherapy is changing the way pancreatic cancer is treated, especially for patients with advanced or treatment-resistant disease. You’ll learn: How immunotherapy trains your immune system to find and destroy cancer cells Why genetic markers like MSI and dMMR improve treatment success What immune checkpoint inhibi…
…
continue reading
1
S13 Ep45: Exploring NCCN Guideline Updates and Advancing Immunotherapy Strategies in Nasopharyngeal Carcinoma: With Neal S. Akhave, MD
10:36
10:36
Play later
Play later
Lists
Like
Liked
10:36
In our conversation, Dr Akhave discussed the addition of toripalimab (Loqtorzi), a PD-1 inhibitor, to the NCCN Guidelines following its launch in the United States. Supported by data from the phase 3 JUPITER-02 trial (NCT03581786), toripalimab is now incorporated into frontline therapy for patients with recurrent metastatic or de novo metastatic Ep…
…
continue reading
1
Clinical Assessment of Alopecia Areata Severity and Validating the Patient Experience: A Vodcast
18:46
18:46
Play later
Play later
Lists
Like
Liked
18:46
In this podcast, Dr. Zoe Apalla from the Aristotle University of Thessaloniki, Thessaloniki, Greece, and Dr. Katya Harfmann from the Nationwide Children’s Hospital, Columbus, OH, USA discuss tools for assessing alopecia areata severity, including the Severity of Alopecia Tool, AA Scale, and AA Severity and Morbidity Index. An interactive digital fe…
…
continue reading
1
Targeted Therapy for Pancreatic Cancer: Personalized Treatment That Improves Outcomes and Comfort
11:58
11:58
Play later
Play later
Lists
Like
Liked
11:58
In this episode, we dive into how targeted therapy is changing the way doctors treat pancreatic cancer, offering hope and a better quality of life for patients facing this challenging disease. You’ll learn: What targeted therapy is and how it differs from chemotherapy How gene mutations like BRCA1, BRCA2, and NTRK fusion influence treatment Why tar…
…
continue reading
1
S13 Ep44: Frank’s Path to Advancing Hematology Through Innovation and Discovery: With Girindra Raval, MD; and David A. Frank, MD, PhD, FACP
40:56
40:56
Play later
Play later
Lists
Like
Liked
40:56
In this episode, Raval welcomed David A. Frank, MD, PhD, FACP, who is director of the Division of Hematology and a professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. He also serves as director of the Winship Innovation Initiative and as an advisor to the Morningside Center for Innovative and Affor…
…
continue reading
1
S13 Ep43: Real-World Perspectives on mCRC and GI Neuroendocrine Neoplasms; With Rocío García-Carbonero, MD, PhD
11:33
11:33
Play later
Play later
Lists
Like
Liked
11:33
In our conversation, Dr García-Carbonero discussed a subgroup analysis from the phase 3 FRESCO-2 trial (NCT04322539), which evaluated fruquintinib (Fruzaqla) in previously treated metastatic CRC (mCRC). She reviewed efficacy outcomes by metastatic site, including liver-only, lung-only, bone, and peritoneal disease. Fruquintinib demonstrated improve…
…
continue reading
1
Available and Emerging Subcutaneous Immunotherapy Treatment Options for Patients With Cancer: A Pharmacy Perspective
24:49
24:49
Play later
Play later
Lists
Like
Liked
24:49
In this episode, listen to Kelly Romo, PharmD, BCOP; and Shauna Kraft, PharmD, BCOP, share their takeaways from a live webinar on available emerging subcutaneous immunotherapy options for patients with cancer including: Basic mechanism of action and role of hyaluronidase in subcutaneous immunotherapy formulation and available dosing/schedules Avail…
…
continue reading
1
S13 Ep42: Endometrial (Uterine) Cancer 2025 UPDATE
12:23
12:23
Play later
Play later
Lists
Like
Liked
12:23
In this episode, OncLive On Air® partnered with Two Onc Docs, Tawagi and Armstrong reviewed key principles in the diagnosis and management of uterine and endometrial cancers, incorporating updates in surgical approaches, adjuvant therapy selection, molecular testing, and the management of rare uterine sarcomas. The discussion outlined the epidemiol…
…
continue reading
1
Chemotherapy for Pancreatic Cancer: What to Expect and How It Helps at Every Stage
10:30
10:30
Play later
Play later
Lists
Like
Liked
10:30
In this episode, we break down how chemotherapy plays a critical role in treating pancreatic cancer, from early stages to advanced cases. You’ll learn: How chemotherapy works to target and kill cancer cells throughout the body When doctors use chemo before or after surgery to improve outcomes The most common drug options, including FOLFIRINOX and G…
…
continue reading
1
S1 Ep174: Navigating AE Management for Cellular Therapy Across Hematologic Cancers
9:06
9:06
Play later
Play later
Lists
Like
Liked
9:06
In a conversation with CancerNetwork® at the 2025 National Immune Cell Effector Therapy (ICE-T) Conference, Tiba Al Sagheer, PharmD, BCOP, BCACP; Rebecca Gonzalez, PharmD, BCOP, FASTCT; and Syeda Saba Kareem PharmD, BCOP, spoke about their presentations on managing adverse effects (AEs) across different hematologic malignancy populations. At the me…
…
continue reading
1
Understanding Surgery for Pancreatic Cancer: Whipple, Distal, and Total Pancreatectomy Explained
14:56
14:56
Play later
Play later
Lists
Like
Liked
14:56
In this episode, we explore the critical role surgery plays in treating pancreatic cancer, especially when diagnosed early in the head, body, or tail of the pancreas. Whether you're a patient, caregiver, or want to learn more, this episode breaks down what to expect before, during, and after surgery. You’ll learn: Why surgery is often the best opti…
…
continue reading
1
Radiation Therapy for Pancreatic Cancer: How Modern Treatments Improve Outcomes and Ease
17:41
17:41
Play later
Play later
Lists
Like
Liked
17:41
Radiation therapy is a powerful tool in the fight against pancreatic cancer, especially for patients with locally advanced disease or those recovering after surgery. In this episode, we break down how radiation works, what to expect during treatment, and how it can improve both outcomes and quality of life. You’ll learn: How radiation therapy targe…
…
continue reading
1
Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
59:02
59:02
Play later
Play later
Lists
Like
Liked
59:02
Dr Benjamin Levy from Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial in Washington, DC, discusses important efficacy and safety data from 2024 related to the use of approved and investigational therapies for localized and advanced non-small cell lung cancer without a targetable mutation. CME information and select publications here.…
…
continue reading
1
Say No to Jargon, Yes to Testing: Oncologists Face Tough Patient Conversations in NSCLC
28:39
28:39
Play later
Play later
Lists
Like
Liked
28:39
As oncologists stand on “the cutting edge” of neoadjuvant treatment for EGFR-mutated lung cancer, how should they conduct complex conversations with patients? Christine M. Lovly, MD, PhD, joins hosts Aakash Desai, MD, MPH; Eric K. Singhi, MD; and Fawzi F. Abu Rous, MD, for an honest discussion about current challenges.…
…
continue reading
1
Switching from Dupilumab to Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis
29:42
29:42
Play later
Play later
Lists
Like
Liked
29:42
This podcast is published open access in Dermatology and Therapy and is fully citeable. You can access the original published podcast article through the Dermatology and Therapy website and by using this link: https://link.springer.com/article/10.1007/s13555-025-01491-2. All conflicts of interest can be found online. This podcast is intended for me…
…
continue reading
1
Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care Module 2
27:10
27:10
Play later
Play later
Lists
Like
Liked
27:10
Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care is an accredited, two-part series led by expert Yelena Y. Janjigian, MD.Building on the foundation of biomarker-driven care, this module focuses on optimizing treatment strategies for patients with esophagogastric cancer. Dr. Janjigian reviews the latest evidence o…
…
continue reading
1
Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care - Module 1
25:39
25:39
Play later
Play later
Lists
Like
Liked
25:39
Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care is an accredited, two-part series led by expert Yelena Y. Janjigian, MD.In module 1, Dr. Janjigian provides an in-depth overview of the latest biomarkers—such as HER2, PD-L1, MMR/MSI-H, CLDN18.2, and FGFR2—and their role in guiding treatment decisions for esophagog…
…
continue reading
1
Additional Advances in Genetic Counseling and Testing in Cancer Care With Filipa Lynce, MD, and Catherine Skefos, MA, MS, CGC
12:36
12:36
Play later
Play later
Lists
Like
Liked
12:36
Genetic testing and counseling are crucial components of precision medicine in cancer care, enabling clinicians to deliver the right care, to the right patient, at the right time. i3 Health’s educational activity, Pathways to Precision: Integrating Genetic Counseling and Testing Into Cancer Care, provides a comprehensive foundation for incorporatin…
…
continue reading
1
Additional Advances in HER2-Mutated NSCLC With Julia Kathleen Rotow, MD + Activity Module 1
24:32
24:32
Play later
Play later
Lists
Like
Liked
24:32
i3 Health recently launched an exciting new online educational activity, “What’s New with HER2: Charting New Paths in NSCLC Care.” This two-part series dives deep into the evolving role of HER2 in non–small cell lung cancer (NSCLC).In a special interview, Dr. Julia Kathleen Rotow—Clinical Director of the Lowe Center for Thoracic Oncology at Dana-Fa…
…
continue reading
